Intensive Care Patients from the First COVID-19 Wave: One-Year Survival after Tocilizumab Treatment

Introduction: An infection by COVID-19 triggers a dangerous cytokine storm, so tocilizumab has been introduced in Italy as an agent blocking the cytokine storm. This paper aims to describe the one-year survival of ICU patients treated with tocilizumab. Methods: This observational study enrolled all...

Descripción completa

Detalles Bibliográficos
Autores principales: Melegari, Gabriele, Giuliani, Enrico, Dallai, Chiara, Veronesi, Lucia, Bertellini, Elisabetta, Osmenaj, Suela, Barbieri, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622280/
https://www.ncbi.nlm.nih.gov/pubmed/34834586
http://dx.doi.org/10.3390/jpm11111234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622280/
https://www.ncbi.nlm.nih.gov/pubmed/34834586
http://dx.doi.org/10.3390/jpm11111234

Ejemplares similares